Provided by Tiger Trade Technology Pte. Ltd.

Ventyx Biosciences, Inc.

13.96
+0.02000.14%
Post-market: 13.95-0.0100-0.07%19:47 EST
Volume:1.46M
Turnover:20.40M
Market Cap:1.00B
PE:-9.31
High:13.96
Open:13.92
Low:13.91
Close:13.94
52wk High:25.00
52wk Low:0.7830
Shares:71.75M
Float Shares:53.56M
Volume Ratio:0.48
T/O Rate:2.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4991
EPS(LYR):-1.9732
ROE:-45.35%
ROA:-28.47%
PB:5.23
PE(LYR):-7.07

Loading ...

Ventyx Biosciences call volume above normal and directionally bullish

TIPRANKS
·
Jan 24

Ventyx Biosciences Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jan 23

Ventyx Biosciences Sets Special Cash Bonuses Amid Lilly Merger

TIPRANKS
·
Jan 23

LifeSci Capital Sticks to Its Hold Rating for Ventyx Biosciences (VTYX)

TIPRANKS
·
Jan 11

Eli Lilly (LLY) Buys Ventyx Biosciences in $1.2 Billion Deal

TIPRANKS
·
Jan 09

Ventyx Biosciences Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
Jan 08

Deals of the day-Mergers and acquisitions

Reuters
·
Jan 08

Ventyx Biosciences Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $14 From $21

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
Jan 08

Hold Rating Maintained on Eli Lilly’s Acquisition of Ventyx Biosciences Amid Limited Upside and NLRP3 Uncertainty

TIPRANKS
·
Jan 08

Ventyx Biosciences Inc : H.c. Wainwright Cuts to Neutral Rating

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences downgraded to Neutral from Buy at UBS

TIPRANKS
·
Jan 08

Eli Lilly (LLY.US) Confirms Acquisition of Ventyx Biosciences (VTYX.US) at $14 Per Share

Stock News
·
Jan 08

BRIEF-Ventyx Biosciences Upon Termination Of Merger Under Specified Circumstances, Co Will Be Required To Pay Eli Lilly Termination Fee Of $44 Million

Reuters
·
Jan 08

BRIEF-Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-Mediated Diseases

Reuters
·
Jan 08

Ventyx Biosciences: Upon Termination of Merger Under Specified Circumstances, Co Will Be Required to Pay Eli Lilly Termination Fee of $44 Mln

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences Inc - Transaction Expected to Close in First Half of 2026

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences Inc - Lilly Will Acquire All of Outstanding Shares of Ventyx for $14.00 per Share

THOMSON REUTERS
·
Jan 08

Ventyx Biosciences Inc - Proposed Deal for Equity Value of Approximately $1.2 Bln

THOMSON REUTERS
·
Jan 08